
AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca/Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic, the report added.
from International-News-Economic Times https://ift.tt/3bKz9Da
via
IFTTT
0 comments:
Post a Comment